EDGAR Filing Documents for 0000878088-10-000019

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0000878088-10-000019

Filing Date

2010-02-25

Accepted

2010-02-25 15:05:00

Documents

Period of Report

2009-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10K	finaledgar200910k22510.htm	10-K	1949826
2	TERMS OF RESTRICTED SHARES AWARD	ex1069rsaterms.htm	EX-10.6.9	41305
3	TERMS OF STOCK OPTION	ex10610stockoptionterms.htm	EX-10.6.10	49340
4	TERMS OF RESTRICTED STOCK UNIT AWARD	ex10611rsuterms.htm	EX-10.6.11	35731
5	AMENDMENT TO LEASE	exh101137thamdtoticelease.htm	EX-10.11.3	48067
6	CODE OF ETHICS	exhibit14codeofethics.htm	EX-14	55808
7	LIST OF SUBSIDIARIES	exhibit21listofsubsidiariesa.htm	EX-21	7750
8	CONSENT OF DELOITTE & TOUCHE LLP	exhibit23dtconsent.htm	EX-23	1848
9	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER	exhibit31ceocert.htm	EX-31.1	7620
10	CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER	exhibit31cfocert.htm	EX-31.2	7577
11	CERTIFICATION OF CEO	exhibit32ceo.htm	EX-32.1	3155
12	CERTIFICATION OF CFO	exhibit32cfo.htm	EX-32.2	3540
13		finaledgar200910k22510002.gif	GRAPHIC	300568
	Complete submission text file	0000878088-10-000019.txt		2627368

Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677

Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000

PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)